Suzuken Overview

  • Year Founded
  • 1932

Year Founded

  • Status
  • Public

  • Employees
  • 16,103

Employees

  • Stock Symbol
  • 9987

Stock Symbol

  • Investments
  • 19

  • Share Price
  • $35.42
  • (As of Monday Closing)

Suzuken General Information

Description

Suzuken Co Ltd is a Japanese drug manufacturer. It functions through four segments: Pharmaceutical Wholesale, which sells pharmaceuticals, diagnostic drugs, and medical equipment and materials; The Pharmaceutical Manufacturing, which produces pharmaceuticals and diagnostic drugs; The Insurance Pharmacy dispenses operations based on prescriptions from medical institutions and the Medical-related Service and Others segment which sells medical books, provides nursing services and manufactures physiological examination equipment.

Contact Information

Website
www.suzuken.co.jp
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 8 Higashi Kataha-machi
  • Higashi-ku
  • Nagoya, Aichi 461-8701
  • Japan
+81
Primary Industry
Pharmaceuticals
Stock Exchange
TKS
Vertical(s)
Manufacturing
Corporate Office
  • 8 Higashi Kataha-machi
  • Higashi-ku
  • Nagoya, Aichi 461-8701
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Suzuken Stock Performance

As of 19-May-2025, Suzuken’s stock price is $35.42. Its current market cap is $2.55B with 72.1M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$35.42 $35.10 $28.12 - $37.21 $2.55B 72.1M 241K $2.98

Suzuken Financials Summary

As of 31-Mar-2025, Suzuken has a trailing 12-month revenue of $15.7B.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023
EV 1,080,152 1,080,152 646,764 164,995
Revenue 15,738,871 15,738,871 16,516,684 17,098,514
EBITDA 407,901 407,901 354,579 288,842
Net Income 226,225 226,225 200,817 150,279
Total Assets 7,443,287 7,443,287 8,118,177 8,601,343
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Suzuken Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Suzuken‘s full profile, request access.

Request a free trial

Suzuken Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Suzuken Co Ltd is a Japanese drug manufacturer. It functions through four segments: Pharmaceutical Wholesale, which sell
Pharmaceuticals
Nagoya, Japan
16,103 As of 2024

Jakarta, Indonesia
 

Tokyo, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Suzuken Competitors (5)

One of Suzuken’s 5 competitors is Taisho Pharmaceutical Indonesia, a Corporation company based in Jakarta, Indonesia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Taisho Pharmaceutical Indonesia Corporation Jakarta, Indonesia
Otsuka Holdings Corporation Tokyo, Japan
Medipal Holdings Corporation Tokyo, Japan
Nipro Corporation Osaka, Japan
ONO Pharmaceutical Corporation Osaka, Japan
You’re viewing 5 of 5 competitors. Get the full list »

Suzuken Patents

  • 136

    Total Documents Applications and Grants

  • Total Patents Families

  • 74

    Granted

  • 25

    Pending

  • Expiring in next 12 mo

Suzuken Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023078842-A Pharmaceuticals etc. selling system and pharmaceuticals etc. selling method Pending 26-Nov-2021
JP-2023050764-A Clinical test drug management system and clinical test drug management method Pending 30-Sep-2021
JP-7140339-B2 Electromagnetic shielding and storage system Active 07-Dec-2020
JP-2021050097-A Electromagnetic shield and storage locker system Active 07-Dec-2020
JP-2022014379-A Electrocardiogram waveform analysis system Active 06-Jul-2020
To view Suzuken’s complete patent history, request access »

Suzuken Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Suzuken Investments & Acquisitions (19)

Suzuken’s most recent deal was a Joint Venture with Medicare Collabo Co.. The deal was made on 01-Feb-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Medicare Collabo Co. 01-Feb-2023 Joint Venture Other Healthcare Services
Ai6 11-Nov-2022 Seed Round Electronics (B2C)
Welby 01-Nov-2022 PIPE Medical Records Systems
Ubie 06-Oct-2022 Later Stage VC Other Healthcare Technology Systems
S-Mat 17-Aug-2022 Later Stage VC Systems and Information Management
You’re viewing 5 of 19 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Suzuken ESG

Risk Overview

Risk Rating

Updated April, 04, 2025

19.66 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,631

Rank

Percentile

Healthcare

Industry

of 563

Rank

Percentile

Medical Distribution

Subindustry

of 45

Rank

Percentile

To view Suzuken’s complete esg history, request access »

Suzuken Exits (2)

Suzuken’s most recent exit was on 01-Oct-2020 from Susmed. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Susmed 01-Oct-2020 Completed
  • 7 buyers
EPS Ekishin 27-Sep-2016 Secondary Transaction - Private Completed
To view Suzuken’s complete exits history, request access »

Suzuken Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Medicare Collabo Co. Nagoya, Japan 2023
Embrace (Healthcare Technology Systems) Tokyo, Japan 2001
Sanki Hiroshima, Japan 1965
Astis Company Matsuyama, Japan 1948
Shoyaku Fukuoka, Japan 1900

Suzuken FAQs

  • When was Suzuken founded?

    Suzuken was founded in 1932.

  • Where is Suzuken headquartered?

    Suzuken is headquartered in Nagoya, Japan.

  • What is the size of Suzuken?

    Suzuken has 16,103 total employees.

  • What industry is Suzuken in?

    Suzuken’s primary industry is Pharmaceuticals.

  • Is Suzuken a private or public company?

    Suzuken is a Public company.

  • What is Suzuken’s stock symbol?

    The ticker symbol for Suzuken is 9987.

  • What is the current stock price of Suzuken?

    As of 19-May-2025 the stock price of Suzuken is $35.42.

  • What is the current market cap of Suzuken?

    The current market capitalization of Suzuken is $2.55B.

  • What is Suzuken’s current revenue?

    The trailing twelve month revenue for Suzuken is $15.7B.

  • Who are Suzuken’s competitors?

    Taisho Pharmaceutical Indonesia, Otsuka Holdings, Medipal Holdings, Nipro, and ONO Pharmaceutical are competitors of Suzuken.

  • What is Suzuken’s annual earnings per share (EPS)?

    Suzuken’s EPS for 12 months was $2.98.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »